ArticleAnimal models and experimental medicine2026
The potency of native postbiotics and paraprobiotics in modulating inflammation by affecting the gut-kidney axis.
Article in Animal models and experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The potency of native postbiotics and paraprobiotics in modulating inflammation by affecting the gut-kidney axis.Animal models and experimental medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe gut's impact on kidney health can be observed through its influence on the gut-kidney axis. However, using paraprobiotic and postbiotic agents may improve gut health and kidney function by affecting signaling pathways. This study aims to assess the anti-inflammatory and autophagy-inducing properties of native postbiotics and paraprobiotics to enhance kidney health by targeting the gut-kidney axis.
methodsIn this animal experiment, colitis was induced in male C57Bl/6 mice using dextran sulfate sodium (DSS), and mice were treated with postbiotics and paraprobiotics consisting of four Lactobacillus and two Bifidobacterium strains. A quantitative polymerase chain reaction assay was conducted to evaluate the gene expression involved in the autophagy process in the kidney.
resultsA significant decrease in weight and colon length and an increase in disease activity index and pathological changes were observed in the DSS group. However, the paraprobiotic and postbiotic mixtures, with more emphasis on postbiotics, were effective in preventing these changes caused by DSS. Exposure to DSS resulted in the downregulation of autophagy-related genes, but this difference was not statistically significant. Both the paraprobiotics and postbiotics increased the expression of genes. The postbiotic mixture had a more pronounced effect in increasing the expression of atg7, atg12, and beclin.
conclusionsOur native postbiotics and paraprobiotics indicated an effective role in reducing inflammation, especially gut and kidney inflammation, through the gut-kidney axis. The administration of these beneficial agents with the least side effects could be considered a suitable complementary treatment for controlling symptoms in patients with inflammatory-related disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.